Fcγ receptors are crucial for the expression of acquired resistance to virulent Salmonella enterica serovar Typhimurium in vivo but are not required for the induction of humoral or T-cell-mediated immunity

Immunology

Volumn 120, Issue 3, 2007, Pages 424-432

  Menager, Nathalie ^a   Foster, Gemma ^a   Ugrinovic, Sanja ^a   Uppington, Hazel ^a   Verbeek, Sjef ^b   Mastroeni, Pietro ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antibody; Fc receptors; Immunity; Infection; Salmonella

Indexed keywords

ANTIBODY; FC RECEPTOR; LIVE VACCINE; SALMONELLOSIS VACCINE; BACTERIUM ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTERIAL VIRULENCE; CELLULAR IMMUNITY; CONTROLLED STUDY; HOST RESISTANCE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IN VIVO STUDY; INFECTION RESISTANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SEROTYPE; TH1 CELL; VACCINATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; FEMALE; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; LIVER; MALE; MICROBIOLOGY; PATHOGENICITY; SPLEEN; T LYMPHOCYTE SUBPOPULATION; VIRULENCE;

ANIMALS; ANTIBODIES, BACTERIAL; FEMALE; IMMUNITY, CELLULAR; LIVER; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, IGG; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; SALMONELLA VACCINES; SPLEEN; T-LYMPHOCYTE SUBSETS; VIRULENCE;

EID: 33846897842     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2006.02527.x     Document Type: Article

References (52)

1. Sheppard M, Webb C, Heath F, Mallows V, Emilianus R, Maskell D, Mastroeni P. Dynamics of bacterial growth and distribution within the liver during Salmonella infection. Cell Microbiol 2003; 5:593-600.
2. Richter-Dahlfors A, Buchan AMJ, Finlay BB. Murine salmonellosis studied by confocal microscopy: Salmonella typhimurium resides intracellularly inside macrophages and exerts a cytotoxic effect on phagocytes in vivo. J Exp Med 1997; 186:569-80.
3. Fields PI, Swanson RV, Haidaris CG, Heffron F. Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. Proc Natl Acad Sci USA 1986; 83:5189-93.
4. Mastroeni P, Clare S, Khan S, Harrison JA, Hormaeche CE, Okamura H, Kurimoto M, Dougan G. Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium. Infect Immun 1999; 67:478-83.
5. Mastroeni P, Arena A, Costa GB, Liberto MC, Bonina L, Hormaeche CE. Serum TNF alpha in mouse typhoid and enhancement of a Salmonella infection by anti-TNF alpha antibodies. Microb Pathog 1991; 11:33-8.
6. Mastroeni P, Harrison JA, Chabalgoity JA, Hormaeche CE. Effect of interleukin 12 neutralization on host resistance and gamma interferon production in mouse typhoid. Infect Immun 1996; 64:189-96.
7. Mastroeni P, Harrison JA, Robinson JH, Clare S, Khan S, Maskell DJ, Dougan G, Hormaeche CE. Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent salmonellae in BALB/c mice: role of gamma interferon and macrophage activation. Infect Immun 1998; 66:4767-76.
8. Everest P, Roberts M, Dougan G. Susceptibility to Salmonella typhimurium infection and effectiveness of vaccination in mice deficient in the tumor necrosis factor alpha p55 receptor. Infect Immun 1998; 66:3355-64.
9. Muotiala A, Makela PH. The role of IFN-gamma in murine Salmonella typhimurium infection. Microb Pathog 1990; 8:135-41.
10. Muotiala A, Makela PH. Role of gamma interferon in late stages of murine salmonellosis. Infect Immun 1993; 61:4248-53.
11. Nauciel C, Espinasse-Maes F. Role of gamma interferon and tumor necrosis factor alpha in resistance to Salmonella typhimurium infection. Infect Immun 1992; 60:450-4.
12. Mastroeni P. Immunity to systemic Salmonella infections. Current Mol Med 2002; 2:393-406.
13. Hirose K, Nishimura H, Matsuguchi T, Yoshikai Y. Endogenous IL-15 might be responsible for early protection by natural killer cells against infection with an avirulent strain of Salmonella choleraesuis in mice. J Leukoc Biol 1999; 66:382-90.
14. Hormaeche CE. The natural resistance of radiation chimeras to S. typhimurium C5. Immunology 1979; 37:329-32.
15. Hormaeche CE, Mastroeni P, Arena A, Uddin J, Joysey HS. T cells do not mediate the initial suppression of a Salmonella infection in the RES. Immunology 1990; 70:247-50.
16. + TCR-alpha beta cells and IFN-gamma in bacterial clearance independent of intracellular location. J Immunol 1996; 156:3321-6.
17. + T cells and T-independent mechanisms in acquired resistance to Salmonella typhimurium infection. J Immunol 1990; 145:1265-9.
18. Mastroeni P, Villarreal-Ramos B, Hormaeche CE. Adoptive transfer of immunity to oral challenge with virulent salmonellae in innately susceptible BALB/c mice requires both immune serum and T cells. Infect Immun 1993; 61:3981-4.
19. - Salmonella vaccines. Microb Pathog 1992; 13:477-91.
20. Parry CM, Hoa NT, Diep TS et al. Value of a single-tube widal test in diagnosis of typhoid fever in Vietnam. J Clin Microbiol 1999; 37:2882-6.
21. Wain J, Diep TS, Ho VA, Walsh AM, Nguyen TT, Parry CM, White NJ. Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. J Clin Microbiol 1998; 36:1683-7.
22. Carter PB, Collins FM. The route of enteric infection in normal mice. J Exp Med 1974; 139:1189-203.
23. Mastroeni P, Sheppard M. Salmonella infections in the mouse model: host resistance factors and in vivo dynamics of bacterial spread and distribution in the tissues. Microbes Infect 2004; 6:398-405.
24. Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol 2001; 19:275-90.
25. Nimmerjahn F, Bruhns P, Horiuchi K, Ravetch JV. FcγRIV. A novel FcR with distinct IGg subclass specificity. Immunity 2005; 23:41-51.
26. Mechetina LV, Najakshin AM, Alabyev BY, Chikaev NA, Taranin AV. Identification of CD16-2, a novel mouse receptor homologous to CD16/Fc gamma RIII. Immunogenetics 2002; 54:463-8.
27. Vazquez-Torres A, Jones-Carson J, Mastroeni P, Ischiropoulos H, Fang FC. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. J Exp Med 2000; 192:227-36.
28. Mastroeni P, Vazquez-Torres A, Fang FC, Xu Y, Khan S, Hormaeche CE, Dougan G. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo. J Exp Med 2000; 192:237-48.
29. Uppington H, Menager N, Boross P, Wood J, Sheppard M, Verbeek S, Mastroeni P. Effect of immune serum and role of individual Fcgamma receptors on the intracellular distribution and survival of Salmonella enterica serovar Typhimurium in murine macrophages. Immunology 2006; 119:147-58.
30. Hoiseth SK, Stocker BA. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981; 291:238-9.
31. Hormaeche CE. Natural resistance to Salmonella typhimurium in different inbred mouse strains. Immunology 1979; 37:311-18.
32. Villarreal B, Mastroeni P, de Hormaeche RD, Hormaeche CE. Proliferative and T-cell specific interleukin (IL-2/IL-4) production responses in spleen cells from mice vaccinated with aroA live attenuated Salmonella vaccines. Microb Pathog 1992; 13:305-15.
33. Demarco de Hormaeche R, Jessop H, Senior K. Gonococcal variants selected by growth in vivo or in vitro have antigenically different LPS. Microb Pathog 1988; 4:289-97.
34. Daeron M. Fc receptor biology. Annu Rev Immunol 1997; 15:203-34.
35. Manca F, Fenoglio D, Li Pira G, Kunkl A, Celada F. Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies. J Exp Med 1991; 173:37-48.
36. Guyre PM, Graziano RF, Goldstein J, Wallace PK, Morganelli PM, Wardwell K, Howell AL. Increased potency of Fc-receptor-targeted antigens. Cancer Immunol Immunother 1997; 45:146-8.
37. Tobar JA, Gonzalez PA, Kalergis AM. Salmonella escape from antigen presentation can be overcome by targeting bacteria to Fc gamma receptors on dendritic cells. J Immunol 2004; 173:4058-65.
38. - Salmonella typhimurium vaccines in the murine typhoid model. Immunology 1997; 90:618-25.
39. Hormaeche CE, Mastroeni P, Harrison JA. Demarco de Hormaeche R, Svenson S, Stocker BA. Protection against oral challenge three months after i.v. Immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen. Vaccine 1996; 14:251-9.
40. Dunlap NE, Benjamin WH Jr, McCall RD Jr, Tilden AB. Briles DE. A 'safe-site' for Salmonella typhimurium is within splenic cells during the early phase of infection in mice. Microb Pathog 1991; 10:297-310.
41. Yrlid U, Svensson M, Hakansson A, Chambers BJ, Ljunggren HG, Wick MJ. In vivo activation of dendritic cells and T cells during Salmonella enterica serovar Typhimurium infection. Infect Immun 2001; 69:5726-35.
42. Salcedo SP, Noursadeghi M, Cohen J, Holden DW. Intracellular replication of Salmonella typhimurium strains in specific subsets of splenic macrophages in vivo. Cell Microbiol 2001; 3:587-97.
43. Bonina L, Costa GB, Mastroeni P. Comparative effect of gentamicin and pefloxacin treatment on the late stages of mouse typhoid. New Microbiol 1998; 21:9-14.
44. Ioan-Facsinay A, de Kimpe SJ, Hellwig SM et al. FcγRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 2002; 16:391-402.
45. Carter RH, Fearon DT. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992; 256:105-7.
46. Baiu DC, Prechl J, Tchorbanov A, Molina HD, Erdei A, Sulica A, Capel PJ, Hazenbos WL. Modulation of the humoral immune response by antibody-mediated antigen targeting to complement receptors and Fc receptors. J Immunol 1999; 162:3125-30.
47. Boackle SA, Morris MA, Holers VM, Karp DR. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells. J Immunol 1998; 161:6537-43.
48. Carroll MC. CD21/CD35 in B cell activation. Semin Immunol 1998; 10:279-86.
49. Thornton BP, Vetvicka V, Ross GD. Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells. Clin Exp Immunol 1996; 104:531-7.
50. -/- (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar Typhimurium and show impaired Th1 T-cell responses to Salmonella antigens. Infect Immun 2000; 68:46-53.
51. -/- mice with Salmonella enterica serovar Typhimurium infection. Infect Immun 2003; 71:6808-19.
52. Clatworthy MR, Smith KG. FcγRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis. J Exp Med 2004; 199:717-23.